Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services( )

Within 2 years after the start of the coronavirus disease 2019 (COVID-19) pandemic, novel severe acute respiratory syndrome coronavirus 2 vaccines were developed, rigorously evaluated in large phase 3 trials, and administered to more than 5 billion individuals globally. However, adverse events of sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Top, Karina A, Chen, Robert T, Levy, Ofer, Ozonoff, Al, Carleton, Bruce, Crawford, Nigel W, Creech, C Buddy, Kochhar, Sonali, Poland, Gregory A, Gutu, Kimberley, Cutland, Clare L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Vaccines Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376276/
https://www.ncbi.nlm.nih.gov/pubmed/35680552
http://dx.doi.org/10.1093/cid/ciac407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376276/
https://www.ncbi.nlm.nih.gov/pubmed/35680552
http://dx.doi.org/10.1093/cid/ciac407

Ejemplares similares